So long Vera! Brenda Blethyn has an "iconic" new role in Channel 4's "bold" A Woman of Substance reboot Markets tumble as ...

The White House on Monday released US President Donald Trump’s “Comprehensive Plan to End the Gaza Conflict,” shortly before Trump’s joint press conference alongside Prime Minister Benjamin Netanyahu, ...

Emma Walmsley, the first woman to lead a big pharma company as CEO, will step down from that post Dec. 31, handing the reins of one of Britain’s premier drugmakers to commercial chief Luke Miels. In a ...

Kent Karemaker says he almost gave up and withdrew into himself after he discovered vandals had taken his car for a damaging joyride in the middle of the night. The 45-year-old, who moved from urban B ...

It's not often that a football playing surface descends into infamy, but MetLife Stadium's artificial turf added to its growing legend when star New York Giants receiver Malik Nabers tore his ACL ...

In an unexpected announcement that has sent the share British pharma major GSK higher by more than 3 percent during trade in London stock exchange, the Chief Executive Office Emma Walmsley is stepping ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Dame Emma Walmsley, CEO of GSK arrives for a ...

Dame Emma Walmsley, CEO of GSK arrives for a business roundtable attended by President Donald Trump and Britain's Prime Minister Keir Starmer at Chequers near ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker LONDON -- GSK ...

GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley following eight years at the helm of the drugmaker. Dame Emma was the first woman to run a major pharmaceutical ...